Solutions for Infectious Disease Control CapitalBio

Respiratory Virus Nucleic Acid Detection

Using isothermal amplification technology, which is based on the synergistic impact of reverse transcription and transcriptase, the reaction is conducted at 41 °C, and a specialized fluorescent probe is employed for real-time fluorescent detection. When combined with the microfluidic platform, it can find six common respiratory viruses, including SARS-CoV-2. 

Why Choose CapitalBio?

• Multiple options to pick from and a vast selection of products

• Have been on the Chinese market for about 20 years, and there is ample clinical data to support its use

• The R&D staff hails from Tsinghua University, where the emphasis is placed on cutting-edge technology

• Each individual client’s needs can be individually met with a tailored set of solutions